The Quantitative Imaging for Personalized Cancer Medicine (QIPCM) program provides end-to-end testing and analysis support for clinical trials to improve consistency and reliability in clinical trial data.

Our infrastructure was designed to help clinical investigators achieve systematic image collection and improved collaboration. Our modular design equips us with capacity to handle large volume functional and dynamic imaging data.

Here’s a short video showcasing QIPCM and its service offerings.

About UHN

University Health Network (UHN) is Canada’s largest research hospital. It is fully affiliated with the University of Toronto and comprises four academic hospitals, an education institute and seven research institutes. The scope of research and complexity of cases at UHN has made it a national and international source for discovery, education and patient care. UHN leads major research programs in cardiology, transplantation, neuroscience, oncology, surgical innovation, infectious disease, genomic medicine, rehabilitation medicine and much more.

QIPCM is an advanced imaging core lab situated within the Techna Institute, a UHN research institute dedicated to accelerating the development and exploitation of technology for health.